Your browser doesn't support javascript.
loading
Rituximab in diffuse cutaneous systemic sclerosis: should we be using it today?
McQueen, Fiona M; Solanki, Kamal.
Afiliação
  • McQueen FM; Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Department of Rheumatology, Greenlane Clinical Centre, Auckland District Health Board, Auckland, Department of Rheumatology, Waikato Hospital and Waikato Clinical School, University of Auckland, Hamilton, New Zealand Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Department of Rheumatology, Greenlane Clinical Centre, Auck
  • Solanki K; Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Department of Rheumatology, Greenlane Clinical Centre, Auckland District Health Board, Auckland, Department of Rheumatology, Waikato Hospital and Waikato Clinical School, University of Auckland, Hamilton, New Zealand Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Department of Rheumatology, Greenlane Clinical Centre, Auck
Rheumatology (Oxford) ; 54(5): 757-67, 2015 May.
Article em En | MEDLINE | ID: mdl-25573841
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos B / Antirreumáticos / Esclerodermia Difusa / Anticorpos Monoclonais Murinos Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos B / Antirreumáticos / Esclerodermia Difusa / Anticorpos Monoclonais Murinos Idioma: En Ano de publicação: 2015 Tipo de documento: Article